Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Genome-wide high-content siRNA screens for regulators of Parkin translocation in selective mitophagy (Ambion Library)
Assay data:9227 Active, 64752 Tested
SummaryPubMed Citation
Antagonist activity at human recombinant urotensin 2 receptor expressed in CHO cells assessed as inhibition of urotensin 2-induced intracellular calcium mobilization
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Antagonist activity at human recombinant urotensin 2 receptor expressed in CHO cells assessed as inhibition of urotensin 2-induced intracellular calcium mobilization at up to 10 uM
Assay data:2 Tested
SummaryPubMed CitationRelated BioAssays by Target
Displacement of [125I]urotensin-2 from human UT2 receptor expressed in CHO-K1 cells by liquid scintillation counting
Assay data:20 Active, 6 Activity ≤ 1 nM, 20 Activity ≤ 1 µM, 20 Tested
Binding affinity to human urotensin-2 receptor
Assay data:18 Active, 1 Activity ≤ 1 nM, 15 Activity ≤ 1 µM, 18 Tested
Agonist activity against human urotensin 2 receptor expressed in human NIH373 cells assessed as beta-galactosidase activity after 5 days by R-SAT assay
Assay data:35 Active, 27 Activity ≤ 1 µM, 37 Tested
Agonist activity against human urotensin 2 receptor expressed in human NIH373 cells assessed as beta-galactosidase activity after 5 days by R-SAT assay relative to urotensin 2
Assay data:36 Tested
Displacement of [125I]urotensin 2 from urotensin 2 receptor in human RMS13 cells by scintillation proximity assay
Assay data:46 Active, 44 Activity ≤ 1 µM, 47 Tested
Antagonist activity at urotensin 2 receptor in human RMS13 cells assessed as inhibition of urotensin 2-induced intracellular calcium mobilization after 1 hr by FLIPR assay
Assay data:31 Active, 29 Activity ≤ 1 µM, 31 Tested
Agonist activity at human GPR14 expressed in HEK293 cells by calcium mobilization assay
Assay data:9 Active, 9 Activity ≤ 1 µM, 9 Tested
Agonist activity at human GPR14 expressed in HEK293 cells by calcium mobilization assay relative to urotensin 2
Assay data:8 Tested
Binding affinity to human urotensin 2 receptor
Assay data:5 Active, 5 Activity ≤ 1 µM, 5 Tested
Agonist activity at human urotensin 2 expressed in CHO cells by FLIPR
Assay data:3 Active, 3 Activity ≤ 1 µM, 3 Tested
Assay data:25 Active, 10 Activity ≤ 1 µM, 29 Tested
Agonist activity against human urotensin 2 receptor expressed in human NIH373 cells assessed as beta-galactosidase activity after 5 days by R-SAT assay relative to Urotensin-2
Assay data:29 Tested
An siRNA screen for human genes that are involved in human papilloma virus (HPV) E2 transcriptional repression of the E6 and E7 oncogenes
Assay data:497 Active, 21019 Tested
Binding affinity to urotensin-2 receptor
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Antagonist activity at recombinant human urotensin2 receptor expressed in CHO cells assessed as inhibition of urotensin2-stimulated Ca2+ mobilization incubated 10 mins prior to urotensin2 stimulation measured after 10 mins by fluorometric analysis
Displacement of [125I]-U2 from recombinant human urotensin2 receptor expressed in human U2OS cells after 30 mins by gamma counting analysis
Antagonist activity at recombinant human urotensin2 receptor expressed in CHO cells assessed as inhibition of urotensin2-stimulated Ca2+ mobilization after 1 hr by FLIPR assay
Assay data:22 Active, 12 Activity ≤ 1 µM, 31 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on